SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-18-007112
Filing Date
2018-06-01
Accepted
2018-06-01 09:00:40
Documents
8
Period of Report
2018-05-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k052918_immudyneinc.htm 8-K 44327
2 FORM OF SECURITIES PURCHASE AGREEMENT f8k052918ex10-1_immudyne.htm EX-10.1 430145
3 FORM OF SENIOR CONVERTIBLE NOTE f8k052918ex10-2_immudyne.htm EX-10.2 162385
4 FORM OF WARRANT f8k052918ex10-3_immudyne.htm EX-10.3 104457
5 FORM OF REGISTRATION RIGHTS AGREEMENT f8k052918ex10-4_immudyne.htm EX-10.4 193278
6 FORM OF LOCK-UP AGREEMENT f8k052918ex10-5_immudyne.htm EX-10.5 61673
7 FORM OF SECURITY AGREEMENT f8k052918ex10-6_immudyne.htm EX-10.6 253133
8 FORM OF GUARANTY AGREEMENT f8k052918ex10-7_immudyne.htm EX-10.7 73742
  Complete submission text file 0001213900-18-007112.txt   1324498
Mailing Address 1460 BROADWAY NEW YORK NY 10036
Business Address 1460 BROADWAY NEW YORK NY 10036 914-244-1777
Immudyne, Inc. (Filer) CIK: 0000948320 (see all company filings)

IRS No.: 760238453 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55857 | Film No.: 18873520
SIC: 2833 Medicinal Chemicals & Botanical Products